Who owns the BRAFTOVI ENCORAFENIB CAPSULES trademark?

The BRAFTOVI ENCORAFENIB CAPSULES trademark is owned by Array Biopharma Inc..

What class is the BRAFTOVI ENCORAFENIB CAPSULES trademark registered in?

The BRAFTOVI ENCORAFENIB CAPSULES trademark is registered in Class 005 (Pharmaceuticals, medical & veterinary preparations).

What is the serial number for BRAFTOVI ENCORAFENIB CAPSULES?

The USPTO serial number for BRAFTOVI ENCORAFENIB CAPSULES is 87756187.

What is the registration number for BRAFTOVI ENCORAFENIB CAPSULES?

BRAFTOVI ENCORAFENIB CAPSULES is registered under USPTO registration number 5625743.

BRA

USPTO Trademark Record

REGISTERED

BRAFTOVI ENCORAFENIB CAPSULES

SN 87756187·Reg 5625743·Filed Jan 16, 2018

Owner Array Biopharma Inc.

Pharmaceuticals, medical and veterinary preparations; sanitary preparations for medical purposes; dietetic food and substances adapted for medical or veterinary purposes, food for babies; dietary supplements for human beings and animals; adhesive plasters, materials for dressings; material for filling teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.

BRAFTOVI ENCORAFENIB CAPSULES (Serial No. 87756187), Registration No. 5625743, is a registered US trademark filed on Jan 16, 2018 by Array Biopharma Inc.. This trademark covers Class 005 (Pharmaceuticals, medical & veterinary preparations).

Section 8/9 declaration window: December 11, 2028

Mark Intelligence

BRAFTOVI ENCORAFENIB CAPSULES (Reg. #5625743) is a registered US trademark that has been protecting its owner, Array Biopharma Inc., since 2018. The mark covers Class 005 (Pharmaceuticals, medical & veterinary preparations). Goods and services include Pharmaceuticals, medical and veterinary preparations; sanitary preparations for medical purposes; dietetic food and subs.... The mark faced 1 opposition proceeding during prosecution.

FILED

Jan 16, 2018

SERIAL

87756187

REG#

5625743

REGISTERED

Dec 11, 2018

Owner

Applicant

Array Biopharma Inc.

Entity

Corporation

State

Address

3200 Walnut Street, Boulder, CO, 80301

Country

Attorney

NameHeather A. McDonald

Law firm

Heather A. McDonald Pfizer Inc.

Docket

T 428593

Address

66 Hudson Boulevard East, New York, NY 10001-2192, United States

Get pre-filing clearance

AI attorney analyzes your proposed mark against USPTO — Go/No-Go verdict, class-by-class risks, and strategy recommendations.

Run clearance

Filing Information

StatusREGISTERED

Filing DateJan 16, 2018

Serial Number87756187

Registration No.5625743

Registration DateDec 11, 2018

Status DateJul 13, 2024

Published for OppositionSep 25, 2018

Next RenewalDecember 11, 2028

Mark TypeDesign with words

Attorney DocketT 428593

Status DescriptionLive and registered, Section 8 and 15 accepted

Filing Signals

FILED

2018

YEARS AGO

CLASSES

MADRID FILINGS

Opposed 1× during prosecution

Search 14M+ trademarks

Free USPTO lookups by name, owner, or serial number. No account needed.

Search now

Full Goods & Services

CLASSES

OFFICE

USPTO

COUNTRY

Class 005Pharmaceuticals, medical & veterinary preparations

US codes: 005, 006, 018, 044, 046, 051, 052

First use anywhere: Jul 02, 2018

First use in commerce: Jul 02, 2018

This description is as filed with the USPTO and defines the scope of trademark protection.

Status History

35 events

REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.

Jul 13, 2024

REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

Jul 13, 2024

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED

Jul 13, 2024

NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED

TEAS SECTION 8 & 15 RECEIVED

Jan 02, 2024

TEAS SECTION 8 & 15 RECEIVED

COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED

Dec 11, 2023

COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED

AMENDMENT UNDER SECTION 7 - PROCESSED

Nov 16, 2020

AMENDMENT UNDER SECTION 7 - PROCESSED

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

Nov 16, 2020

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

TEAS SECTION 7 REQUEST RECEIVED

Jul 16, 2020

TEAS SECTION 7 REQUEST RECEIVED

APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED

Jun 04, 2020

APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

Jun 04, 2020

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

Jun 04, 2020

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

TEAS CHANGE OF CORRESPONDENCE RECEIVED

Jun 04, 2020

TEAS CHANGE OF CORRESPONDENCE RECEIVED

TEAS CHANGE OF OWNER ADDRESS RECEIVED

Jun 04, 2020

TEAS CHANGE OF OWNER ADDRESS RECEIVED

REGISTERED-PRINCIPAL REGISTER

Dec 11, 2018

REGISTERED-PRINCIPAL REGISTER

PUBLISHED FOR OPPOSITION

Sep 25, 2018

PUBLISHED FOR OPPOSITION

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

Sep 25, 2018

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

Sep 05, 2018

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

ASSIGNED TO LIE

Aug 21, 2018

ASSIGNED TO LIE

EXAMINER'S AMENDMENT ENTERED

Aug 09, 2018

EXAMINER'S AMENDMENT ENTERED

APPROVED FOR PUB - PRINCIPAL REGISTER

Aug 09, 2018

APPROVED FOR PUB - PRINCIPAL REGISTER

NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

Aug 09, 2018

NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

EXAMINERS AMENDMENT E-MAILED

Aug 09, 2018

EXAMINERS AMENDMENT E-MAILED

EXAMINERS AMENDMENT -WRITTEN

Aug 09, 2018

EXAMINERS AMENDMENT -WRITTEN

NOTICE OF ACCEPTANCE OF AMENDMENT TO ALLEGE USE E-MAILED

Jul 13, 2018

NOTICE OF ACCEPTANCE OF AMENDMENT TO ALLEGE USE E-MAILED

USE AMENDMENT ACCEPTED

Jul 12, 2018

USE AMENDMENT ACCEPTED

USE AMENDMENT FILED

Jul 11, 2018

USE AMENDMENT FILED

AMENDMENT TO USE PROCESSING COMPLETE

Jul 11, 2018

AMENDMENT TO USE PROCESSING COMPLETE

TEAS AMENDMENT OF USE RECEIVED

Jul 10, 2018

TEAS AMENDMENT OF USE RECEIVED

NON-FINAL ACTION E-MAILED

May 03, 2018

NON-FINAL ACTION E-MAILED

NOTIFICATION OF NON-FINAL ACTION E-MAILED

May 03, 2018

NOTIFICATION OF NON-FINAL ACTION E-MAILED

NON-FINAL ACTION WRITTEN

May 03, 2018

NON-FINAL ACTION WRITTEN

ASSIGNED TO EXAMINER

Apr 26, 2018

ASSIGNED TO EXAMINER

NOTICE OF DESIGN SEARCH CODE E-MAILED

Jan 30, 2018

NOTICE OF DESIGN SEARCH CODE E-MAILED

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

Jan 28, 2018

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

NEW APPLICATION ENTERED

Jan 19, 2018

NEW APPLICATION ENTERED

BRAFTOVI ENCORAFENIB CAPSULES

Get pre-filing clearance

Search 14M+ trademarks

Run a conflict check

Other Marks by Array Biopharma Inc.

Other Marks in Class 005 — Pharmaceuticals, medical & veterinary preparations

Other Marks by Heather A. McDonald

Resources

Company